$3.14M
Revenue
$-3.35M
Net Income
22.63%
Gross Margin
-
Op. Margin
$-1.97M
Free Cash Flow
| Breakdown | TTM (Sep 30, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
FY 2020 (Dec 31, 2020) |
|---|---|---|---|---|---|---|
| Total Revenue | $3.14M | - | - | $98.32K | - | $48.00 |
| Revenue Growth % | nan% | nan% | -100.0% | nan% | -100.0% | nan% |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | $710.37K | - | - | $98.32K | - | $48.00 |
| Gross Margin % | 22.6% | nan% | nan% | 100.0% | nan% | 100.0% |
| Operating Expenses | $4.09M | $3.00M | $215.48K | $339.38K | $172.23K | $168.40K |
| Research & Development | - | $745.02K | - | - | - | - |
| Operating Income | - | $-3.00M | $-215.48K | - | - | - |
| Operating Margin % | nan% | nan% | nan% | nan% | nan% | nan% |
| Interest Expense | - | - | - | - | - | - |
| Net Income | $-3.35M | $-3.27M | $-215.39K | $-240.99K | $-172.17K | $-167.77K |
| Net Margin % | -106.8% | nan% | nan% | -245.1% | nan% | -349527.1% |
| Basic EPS | -0.05 | -0.06 | -0.01 | -0.01 | -0.01 | nan |
| Diluted EPS | nan | nan | nan | -0.01 | -0.01 | nan |
| Basic Shares Outstanding | - | - | - | 34.6M | 11.9M | - |
| Diluted Shares Outstanding | - | - | - | 34.6M | 11.9M | - |
| Breakdown | FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
FY 2020 (Dec 31, 2020) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $107.47K | $240.00 | $10.67K | $264.00 | $413.00 |
| Accounts Receivable | - | - | $25.00K | - | - |
| Total Current Assets | $113.97K | $240.00 | $35.67K | $264.00 | $413.00 |
| Total Assets | $113.97K | $240.00 | $35.67K | $264.00 | $413.00 |
| Total Current Liabilities | $1.03M | $332.72K | $227.67K | $1.26M | $1.09M |
| Total Liabilities | $1.03M | $332.72K | - | $1.26M | $1.09M |
| Common Stock | $6.77K | $4.20K | $4.20K | $11.79K | $11.79K |
| Retained Earnings | $-34.33M | $-29.30M | $-29.08M | $-28.84M | $-28.67M |
| Total Stockholders Equity | $-697.30K | $-110.59K | $29.79K | $-1.04M | $-868.59K |
| Total Liabilities & Equity | $113.97K | $240.00 | $35.67K | $264.00 | $413.00 |
| Breakdown | TTM (Sep 30, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
FY 2020 (Dec 31, 2020) |
|---|---|---|---|---|---|---|
| Net Income | $-3.35M | $-3.27M | $-215.39K | $-240.99K | $-172.17K | $-167.77K |
| Stock-based Compensation | $1.91M | $1.17M | - | - | - | - |
| Change in Receivables | - | - | $-25.00K | $25.00K | - | - |
| Operating Cash Flow | $-1.97M | $-1.65M | $-47.53K | $-45.02K | $-28.50K | $-23.77K |
| Investing Cash Flow | $319.81K | - | - | - | - | - |
| Stock Issued | - | - | - | $49.93K | - | - |
| Financing Cash Flow | $1.70M | $1.76M | $37.10K | $55.43K | $28.35K | $23.33K |
| Net Change in Cash | - | - | - | - | $-149.00 | $-440.00 |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $3.14M | - | $3.14M | - |
| Gross Profit | $710.37K | - | $710.37K | - |
| Operating Expenses | $1.68M | - | $2.83M | - |
| Research & Development | - | - | - | - |
| Operating Income | $-972.17K | - | $-2.12M | - |
| Interest Expense | - | - | - | - |
| Other Income/Expense | $11.06K | - | $11.06K | - |
| Income Before Tax | $-961.11K | - | $-2.11M | - |
| Income Tax Expense | $-3.49K | - | $-3.49K | - |
| Net Income | $-945.79K | $-750.02K | $-2.11M | - |
| Basic EPS | -0.01 | - | -0.03 | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $426.30K | $107.47K |
| Accounts Receivable | $1.46M | - |
| Total Current Assets | $3.86M | $113.97K |
| Property Plant & Equipment | $143.31K | - |
| Goodwill | $4.43M | - |
| Intangible Assets | $14.47M | - |
| Accounts Payable | $2.66M | $482.46K |
| Accrued Liabilities | $836.09K | - |
| Total Current Liabilities | $6.30M | $1.03M |
| Deferred Tax Liabilities | $83.69K | - |
| Total Liabilities | $6.50M | $1.03M |
| Common Stock | $7.61K | $6.77K |
| Retained Earnings | $-36.44M | $-34.33M |
| Total Stockholders Equity | $17.55M | $-697.30K |
| Total Liabilities & Equity | $23.82M | $113.97K |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-945.79K | $-750.02K | $-2.11M | - |
| Depreciation & Amortization | - | - | $8.22K | - |
| Stock-based Compensation | - | - | $856.82K | - |
| Change in Receivables | - | - | $183.23K | - |
| Operating Cash Flow | - | - | $-503.43K | - |
| Capital Expenditure | - | - | $39.50K | - |
| Investing Cash Flow | - | - | $190.90K | - |
| Financing Cash Flow | - | - | $633.64K | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.